Monash University Indonesia, Tangerang Selatan, Indonesia.
Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
PLoS One. 2023 Mar 30;18(3):e0283805. doi: 10.1371/journal.pone.0283805. eCollection 2023.
Data on coronavirus disease 2019 (COVID-19) clinical characteristics and severity from resource-limited settings are limited. This study examined clinical characteristics and factors associated with COVID-19 mortality and hospitalisation in rural settings of Indonesia, from 1 January to 31 July, 2021.
This retrospective cohort included individuals diagnosed with COVID-19 based on polymerase chain reaction or rapid antigen diagnostic test, from five rural provinces in Indonesia. We extracted demographic and clinical data, including hospitalisation and mortality from a new piloted COVID-19 information system named Sistem Informasi Surveilans Epidemiologi (SISUGI). We used mixed-effect logistic regression to examine factors associated with COVID-19-related mortality and hospitalisation.
Of 6,583 confirmed cases, 205 (3.1%) died and 1,727 (26.2%) were hospitalised. The median age was 37 years (Interquartile range 26-51), with 825 (12.6%) under 20 years, and 3,371 (51.2%) females. Most cases were symptomatic (4,533; 68.9%); 319 (4.9%) had a clinical diagnosis of pneumonia and 945 (14.3%) presented with at least one pre-existing comorbidity. Age-specific mortality rates were 0.9% (2/215) for 0-4 years; 0% (0/112) for 5-9 years; 0% (1/498) for 10-19 years; 0.8% (11/1,385) for 20-29 years; 0.9% (12/1,382) for 30-39 years; 2.1% (23/1,095) for 40-49 years; 5.4% (57/1,064) for 50-59 years; 10.8% (62/576) for 60-69 years; 15.9% (37/232) for ≥70 years. Older age, pre-existing diabetes, chronic kidney disease, liver diseases, malignancy, and pneumonia were associated with higher risk of mortality and hospitalisation. Pre-existing hypertension, cardiac diseases, COPD, and immunocompromised condition were associated with risk of hospitalisation but not with mortality. There was no association between province-level density of healthcare workers with mortality and hospitalisation.
The risk of COVID-19-related mortality and hospitalisation was associated with higher age, pre-existing chronic comorbidities, and clinical pneumonia. The findings highlight the need for prioritising enhanced context-specific public health action to reduce mortality and hospitalisation risk among older and comorbid rural populations.
来自资源有限环境的关于 2019 年冠状病毒病(COVID-19)临床特征和严重程度的数据有限。本研究旨在探讨 2021 年 1 月 1 日至 7 月 31 日印度尼西亚农村地区 COVID-19 的临床特征和与死亡率及住院相关的因素。
本回顾性队列研究纳入了基于聚合酶链反应或快速抗原诊断检测在印度尼西亚五个农村省份确诊的 COVID-19 患者。我们从一个名为 Sistem Informasi Surveilans Epidemiologi(SISUGI)的新试点 COVID-19 信息系统中提取了人口统计学和临床数据,包括住院和死亡率。我们使用混合效应逻辑回归来研究与 COVID-19 相关的死亡率和住院的相关因素。
在 6583 例确诊病例中,有 205 例(3.1%)死亡,1727 例(26.2%)住院。中位年龄为 37 岁(四分位距 26-51),205 例(12.6%)年龄<20 岁,3371 例(51.2%)为女性。大多数患者有症状(4533 例;68.9%);319 例(4.9%)有肺炎的临床诊断,945 例(14.3%)有至少一种预先存在的合并症。特定年龄的死亡率为:0-4 岁为 0.9%(2/215);5-9 岁为 0%(0/112);10-19 岁为 0%(1/498);20-29 岁为 0.8%(11/1385);30-39 岁为 0.9%(12/1382);40-49 岁为 2.1%(23/1095);50-59 岁为 5.4%(57/1064);60-69 岁为 10.8%(62/576);≥70 岁为 15.9%(37/232)。年龄较大、合并糖尿病、慢性肾脏病、肝脏疾病、恶性肿瘤和肺炎与更高的死亡风险和住院风险相关。合并高血压、心脏病、COPD 和免疫功能低下与住院风险相关,但与死亡率无关。医护人员密度与死亡率和住院率之间无关联。
COVID-19 相关死亡率和住院率与较高的年龄、预先存在的慢性合并症和临床肺炎有关。这些发现强调需要优先采取有针对性的具体国情公共卫生措施,以降低农村地区老年和合并症患者的死亡和住院风险。